U.S Physical Therapy EPS - Earnings per Share 2012-2026 | USPH

U.S Physical Therapy eps - earnings per share from 2012 to 2026. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
U.S Physical Therapy Annual EPS
2025 $1.42
2024 $1.84
2023 $1.28
2022 $2.25
2021 $2.41
2020 $2.48
2019 $2.45
2018 $1.31
2017 $1.76
2016 $1.64
2015 $1.66
2014 $1.57
2013 $1.05
2012 $1.51
2011 $1.75
U.S Physical Therapy Quarterly EPS
2026-03-31 $-0.12
2025-12-31 $-0.44
2025-09-30 $0.48
2025-06-30 $0.58
2025-03-31 $0.80
2024-12-31 $0.52
2024-09-30 $0.39
2024-06-30 $0.47
2024-03-31 $0.46
2023-12-31 $-0.45
2023-09-30 $0.51
2023-06-30 $0.64
2023-03-31 $0.58
2022-12-31 $-0.01
2022-09-30 $0.72
2022-06-30 $0.87
2022-03-31 $0.67
2021-12-31 $0.72
2021-09-30 $0.66
2021-06-30 $0.82
2021-03-31 $0.21
2020-12-31 $0.68
2020-09-30 $0.61
2020-06-30 $0.99
2020-03-31 $0.20
2019-12-31 $0.55
2019-09-30 $0.66
2019-06-30 $0.85
2019-03-31 $0.39
2018-12-31 $0.43
2018-09-30 $0.13
2018-06-30 $0.48
2018-03-31 $0.27
2017-12-31 $0.58
2017-09-30 $0.41
2017-06-30 $0.39
2017-03-31 $0.38
2016-12-31 $0.42
2016-09-30 $0.38
2016-06-30 $0.48
2016-03-31 $0.36
2015-12-31 $0.37
2015-09-30 $0.47
2015-06-30 $0.48
2015-03-31 $0.34
2014-12-31 $0.35
2014-09-30 $0.43
2014-06-30 $0.52
2014-03-31 $0.27
2013-12-31 $0.31
2013-09-30 $0.02
2013-06-30 $0.41
2013-03-31 $0.31
2012-12-31 $0.34
2012-09-30 $0.38
2012-06-30 $0.41
2012-03-31 $0.38
2011-12-31 $0.69
2011-09-30 $0.34
2011-06-30 $0.41
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.157B $0.781B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $29.514B 13.37
Quest Diagnostics (DGX) United States $21.197B 19.44
Elanco Animal Health (ELAN) United States $11.500B 24.35
Encompass Health (EHC) United States $10.662B 19.64
DaVita (DVA) United States $10.023B 13.82
Chemed (CHE) United States $5.639B 19.57
Option Care Health (OPCH) United States $4.553B 18.71
RadNet (RDNT) United States $4.302B 142.13
LifeStance Health (LFST) United States $2.495B 320.00
Addus HomeCare (ADUS) United States $1.719B 16.61
Astrana Health (ASTH) United States $1.536B 31.40
Aveanna Healthcare Holdings (AVAH) United States $1.353B 12.20
Pennant (PNTG) United States $1.072B 31.31
Daxor (DXR) United States $0.048B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.032B 0.00
Psychemedics (PMD) United States $0.000B 0.00